Instrument Inactif

Autres langues Össur hf. Other OTC

Actions

Embla Medical hf: Interim Report Q1 2024	23/04
Embla Medical hf. Provides Earnings Guidance for the Year 2024	23/04
Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04
Össur hf. will Change its Name to Embla Medical hf	08/04
Össur hf: Board Decisions Following the Annual General Meeting	13/03
Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee	13/03
Össur hf: Results of the Annual General Meeting	13/03
Össur hf: Candidates to the Board of Directors	10/03
Össur hf: Final Agenda and Proposals for the Annual General Meeting 13 March 2024	28/02
Össur hf: Össur establishes new parent organization to be named Embla Medical	21/02
Össur hf Establishes New Parent Organization to Be Named Embla Medical	21/02
Össur hf: Annual General Meeting 13 March 2024	21/02
Össur hf: Annual Report 2023	30/01
Össur hf: Interim Report Q4 2023	30/01
Össur hf. Reports Earnings Results for the Full Year Ended December 31, 2023	30/01
Össur hf. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	30/01
Össur hf. Provides Earnings Guidance for the Year 2024	30/01
Össur hf: Össur's total share capital following completion of capital increase of 6,636,122 shares	24/01
Iceland's Össur to Purchase Fior & Gentz	16/01
Össur hf: Össur acquires FIOR & GENTZ	16/01

Aucun résultat pour cette recherche